These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20499076)

  • 1. IVF conversion to IUI in poor responders: an observational study.
    Freour T; Dubourdieu S; Mirallie S; Langlois ML; Jean M; Barrière P
    Arch Gynecol Obstet; 2010 Oct; 282(4):445-9. PubMed ID: 20499076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting an IVF cycle to IUI in low responders with at least 2 follicles.
    Matorras R; Corcóstegui B; Mendoza R; Ramón O; Aparicio V; Uriarte MT; Rodríguez-Escudero FJ
    J Reprod Med; 2003 Oct; 48(10):789-91. PubMed ID: 14619646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature.
    Merviel P; Heraud MH; Grenier N; Lourdel E; Sanguinet P; Copin H
    Fertil Steril; 2010 Jan; 93(1):79-88. PubMed ID: 18996517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of rescue in vitro fertilization converted from high-response gonadotropin intrauterine insemination cycles in terms of implantation and pregnancy rates as compared with matched controls.
    Haydardedeoglu B; Bagis T; Simsek E; Cok T; Hacivelioglu SO; Erkanli S
    Fertil Steril; 2009 Jul; 92(1):137-42. PubMed ID: 18692785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N; Sylvestre C; Tulandi T; Buckett W
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment for poor responders to ovarian stimulation: does in vitro insemination offer any advantages to intrauterine insemination?
    Wood S; Rahim R; Searle T; Sajjad Y; Troup S; Lewis-Jones I; Kingsland C
    Hum Fertil (Camb); 2003 Feb; 6(1):13-8. PubMed ID: 12663956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
    Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
    Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine insemination.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2009; 15(3):265-77. PubMed ID: 19240042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve.
    Chou LL; Hwu YM; Lin MH; Lin SY; Lee RK
    Taiwan J Obstet Gynecol; 2010 Dec; 49(4):442-8. PubMed ID: 21199746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option?
    Quinquin M; Mialon O; Isnard V; Massin N; Parinaud J; Delotte J; Bongain A
    Fertil Steril; 2014 Dec; 102(6):1596-601. PubMed ID: 25256936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
    Erdem A; Erdem M; Atmaca S; Guler I
    Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Iwase A; Ando H; Kuno K; Mizutani S
    Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
    Urbancsek J; Hauzman EE; Murber A; Lagarde AR; Rabe T; Papp Z; Strowitzki T
    Gynecol Endocrinol; 2005 Jul; 21(1):38-44. PubMed ID: 16048800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pregnancy rates in pre-treatment male infertility and low total motile sperm count at insemination.
    Xiao CW; Agbo C; Dahan MH
    Arch Gynecol Obstet; 2016 Jan; 293(1):211-217. PubMed ID: 26288981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Rode A; Mitwally MF; Puscheck EE
    Fertil Steril; 2008 Apr; 89(4):998-1001. PubMed ID: 17678904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Carmona F; Casamitjana R; Vanrell JA; Balasch J
    Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.